These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15182733)

  • 1. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
    Shen C; Bullens D; Kasran A; Maerten P; Boon L; Aerts JM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
    Int Immunopharmacol; 2004 Jul; 4(7):939-51. PubMed ID: 15182733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
    Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
    Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucosylceramide synthase inhibitor N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin induces sterol regulatory element-binding protein-regulated gene expression and cholesterol synthesis in HepG2 cells.
    Bijl N; Scheij S; Houten S; Boot RG; Groen AK; Aerts JM
    J Pharmacol Exp Ther; 2008 Sep; 326(3):849-55. PubMed ID: 18550691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C
    Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice.
    Shen C; Dillissen E; Kasran A; Lin Y; Herman J; Sienaert I; De Jonghe S; Kerremans L; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
    Clin Immunol; 2007 Jan; 122(1):53-61. PubMed ID: 17070110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
    Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
    Shen C; Dillissen E; Kasran A; Lin Y; Clydesdale G; Sienaert I; Jonghe SD; Gao LJ; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
    J Interferon Cytokine Res; 2006 Aug; 26(8):575-82. PubMed ID: 16881868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
    Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
    Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
    Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
    Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats.
    Kono H; Fujii H; Ogiku M; Tsuchiya M; Ishii K; Hara M
    Transl Res; 2010 Nov; 156(5):282-91. PubMed ID: 20970751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
    Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q
    Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia (Designated as MAK) ameliorates murine colitis induced by trinitrobenzene sulphonic acid.
    Hanaoka R; Ueno Y; Tanaka S; Nagai K; Onitake T; Yoshioka K; Chayama K
    Scand J Immunol; 2011 Nov; 74(5):454-62. PubMed ID: 21973321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
    Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.
    Ishiguro K; Ando T; Maeda O; Hasegawa M; Kadomatsu K; Ohmiya N; Niwa Y; Xavier R; Goto H
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):35-42. PubMed ID: 16928387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.